Assunção-Costa Lindemberg, Pinto Charleston Ribeiro, Machado Juliana Ferreira Fernandes, Valli Cleidenete Gomes, de Souza Luis Eugenio Portela Fernandes
Department of Medicine, School of Pharmacy, Federal University of Bahia and National Institute for Phamaceutical Assistence and Pharmacoeconomy - INAFF, Rua Barão de Jeremoabo, 147, 2º andar, Campus Ondina, Salvador, Bahia, 40170-115, Brazil.
Department of Medicine, School of Pharmacy, Federal University of Bahia, Salvador, Bahia, Brazil.
J Pharm Policy Pract. 2023 Nov 14;16(1):143. doi: 10.1186/s40545-023-00653-x.
Epidemiological data on medication errors severity are scarce. The assessment of the prevalence and severity of medication errors may be limited because of several reasons, including a lack of standardization in the method of identifying medication administration errors and little knowledge about the appropriate assessment tools to measure severity. Thus, in this study, we aim to assess the potential severity of errors identified by direct observation in a teaching hospital.
We used a validated method for assessing the potential severity of medication administration errors. Responses are scored on a 10-point scale. The 203 errors identified in a previous study were organized per similarity, resulting in 67 errors. This list was assessed by a panel of a physician, a nurse, and two pharmacists. The average score for each of the 67 errors was estimated considering the scores given by the 4 judges. Errors with a severity index < 3, between 3 and 7, and > 7 were considered minor, moderate, and severe, respectively.
Professionals classified the potential clinical significance of the errors as minor, moderate, and severe in 8.8% (18/203), 82.8% (168/203), and 8.4% (17/203) of the cases, respectively. Most errors considered potentially serious (41%, 7/17) were technical errors. Most potentially serious errors involved insulin. Regarding the administration route, nine (53%) potentially serious errors involved medications administered intravenously.
Most of the errors were considered as potentially moderated by the expert panel; however, the frequency of potentially serious errors was higher than that in previous studies using the same methodology, which highlights the need for strategies to reduce their occurrence.
关于用药错误严重程度的流行病学数据匮乏。由于多种原因,用药错误发生率和严重程度的评估可能受到限制,包括识别用药错误方法缺乏标准化以及对衡量严重程度的适当评估工具了解不足。因此,在本研究中,我们旨在评估教学医院中通过直接观察识别出的错误的潜在严重程度。
我们使用一种经过验证的方法来评估用药错误的潜在严重程度。回答按10分制评分。先前研究中识别出的203个错误按相似性进行整理,得到67个错误。该列表由一名医生、一名护士和两名药剂师组成的小组进行评估。考虑4名评判给出的分数,估计67个错误中每个错误的平均得分。严重程度指数<3、3至7和>7的错误分别被视为轻微、中度和严重。
专业人员将这些错误的潜在临床意义分别归类为轻微、中度和严重,比例分别为8.8%(18/203)、82.8%(168/203)和8.4%((17/203)。大多数被认为可能严重的错误(41%,7/17)是技术错误。大多数潜在严重错误涉及胰岛素。关于给药途径,9个(53%)潜在严重错误涉及静脉给药。
专家小组认为大多数错误可能为中度;然而,潜在严重错误的发生率高于以往使用相同方法的研究,这突出了采取策略减少其发生的必要性。